Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Keros Therapeutics, Inc. | 150,047 | reported | 21 Nov 2025 | tx 277+969,252−1,809,552 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 Nov 2025 | OTHER | Keros Therapeutics, Inc. | 191,527 | 17.75 USD | |
| 21 Nov 2025 | OTHER | Keros Therapeutics, Inc. | 130,494 | 17.75 USD | |
| 04 Jun 2025 | GRANT_AWARD | Keros Therapeutics, Inc. | 5,250 | 0.00 USD | |
| 04 Jun 2025 | GRANT_AWARD | Keros Therapeutics, Inc. | 10,500 | 0.00 USD | deriv |
| 30 May 2024 | GRANT_AWARD | Keros Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 06 Jun 2023 | GRANT_AWARD | Keros Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 13 Apr 2020 | PURCHASE | Keros Therapeutics, Inc. | 1,191 | 20.98 USD | |
| 01 Jun 2022 | GRANT_AWARD | Keros Therapeutics, Inc. | 8,293 | 0.00 USD | deriv |
| 04 Jan 2022 | SALE | Keros Therapeutics, Inc. | 524 | 54.95 USD | |
| 04 Jan 2022 | SALE | Keros Therapeutics, Inc. | 2,124 | 56.10 USD | |
| 04 Jan 2022 | SALE | Keros Therapeutics, Inc. | 1,383 | 56.10 USD | |
| 03 Jan 2022 | SALE | Keros Therapeutics, Inc. | 3,678 | 56.82 USD | |
| 04 Jan 2022 | SALE | Keros Therapeutics, Inc. | 1,707 | 56.95 USD | |
| 04 Jan 2022 | SALE | Keros Therapeutics, Inc. | 1,113 | 56.95 USD | |
| 04 Jan 2022 | SALE | Keros Therapeutics, Inc. | 4,151 | 57.99 USD | |
| 04 Jan 2022 | SALE | Keros Therapeutics, Inc. | 2,704 | 57.99 USD | |
| 04 Jan 2022 | SALE | Keros Therapeutics, Inc. | 3,367 | 58.86 USD | |
| 04 Jan 2022 | SALE | Keros Therapeutics, Inc. | 2,195 | 58.86 USD | |
| 05 Jan 2022 | SALE | Keros Therapeutics, Inc. | 419 | 57.23 USD | |
| 05 Jan 2022 | SALE | Keros Therapeutics, Inc. | 271 | 57.23 USD | |
| 05 Jan 2022 | SALE | Keros Therapeutics, Inc. | 1,356 | 58.20 USD | |
| 05 Jan 2022 | SALE | Keros Therapeutics, Inc. | 886 | 58.20 USD | |
| 05 Jan 2022 | SALE | Keros Therapeutics, Inc. | 667 | 59.00 USD | |
| 05 Jan 2022 | SALE | Keros Therapeutics, Inc. | 435 | 59.00 USD | |
| 03 Jan 2022 | SALE | Keros Therapeutics, Inc. | 162 | 59.40 USD |